An unknown buyer agreed to acquire 7.3% stake in Riken Vitamin Co., Ltd. (TSE:4526) from Takeda Pharmaceutical Company Limited (TSE:4502) on February 22, 2018. Under the terms of transaction, Takeda Pharmaceutical Company Limited will sell 1.2 million shares. Upon completion, Takeda Pharmaceutical Company Limited will hold 0.88 million shares. The transaction is expected to be completed by February 27, 2018.

An unknown buyer cancelled the acquisition of 7.3% stake in Riken Vitamin Co., Ltd. (TSE:4526) from Takeda Pharmaceutical Company Limited (TSE:4502) on February 22, 2019.